373 related articles for article (PubMed ID: 2440058)
21. Amphetamine-induced dopamine release in the rat striatum: an in vivo microdialysis study.
Butcher SP; Fairbrother IS; Kelly JS; Arbuthnott GW
J Neurochem; 1988 Feb; 50(2):346-55. PubMed ID: 2447237
[TBL] [Abstract][Full Text] [Related]
22. Sparing of behavior and basal extracellular dopamine after 6-hydroxydopamine lesions of the nigrostriatal pathway in rats exposed to a prelesion sensitizing regimen of amphetamine.
Moroz IA; Peciña S; Schallert T; Stewart J
Exp Neurol; 2004 Sep; 189(1):78-93. PubMed ID: 15296838
[TBL] [Abstract][Full Text] [Related]
23. An escalating dose "binge" model of amphetamine psychosis: behavioral and neurochemical characteristics.
Segal DS; Kuczenski R
J Neurosci; 1997 Apr; 17(7):2551-66. PubMed ID: 9065515
[TBL] [Abstract][Full Text] [Related]
24. Maintenance of amphetamine-induced stereotypy and locomotion requires ongoing dopamine receptor activation.
Conti LH; Segal DS; Kuczenski R
Psychopharmacology (Berl); 1997 Mar; 130(2):183-8. PubMed ID: 9106917
[TBL] [Abstract][Full Text] [Related]
25. Behavioral sensitization: characterization of enduring changes in rotational behavior produced by intermittent injections of amphetamine in male and female rats.
Robinson TE
Psychopharmacology (Berl); 1984; 84(4):466-75. PubMed ID: 6441946
[TBL] [Abstract][Full Text] [Related]
26. Individual differences in amphetamine sensitization, behavior and central monoamines.
Scholl JL; Feng N; Watt MJ; Renner KJ; Forster GL
Physiol Behav; 2009 Mar; 96(3):493-504. PubMed ID: 19103211
[TBL] [Abstract][Full Text] [Related]
27. Amphetamine levels in brain microdialysate, caudate/putamen, substantia nigra and plasma after dosage that produces either behavioral or neurotoxic effects.
Clausing P; Gough B; Holson RR; Slikker W; Bowyer JF
J Pharmacol Exp Ther; 1995 Aug; 274(2):614-21. PubMed ID: 7636721
[TBL] [Abstract][Full Text] [Related]
28. Sensitization to systemic amphetamine produces an enhanced locomotor response to a subsequent intra-accumbens amphetamine challenge in rats.
Paulson PE; Robinson TE
Psychopharmacology (Berl); 1991; 104(1):140-1. PubMed ID: 1882000
[TBL] [Abstract][Full Text] [Related]
29. Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis.
Kuczenski R; Segal D
J Neurosci; 1989 Jun; 9(6):2051-65. PubMed ID: 2566664
[TBL] [Abstract][Full Text] [Related]
30. Long-term decreases in striatal dopamine, 3,4-dihydroxyphenylacetic acid, and homovanillic acid after a single injection of amphetamine in iprindole-treated rats: time course and time-dependent interactions with amfonelic acid.
Steranka LR
Brain Res; 1982 Feb; 234(1):123-36. PubMed ID: 7059818
[TBL] [Abstract][Full Text] [Related]
31. Inbred Lewis and Fischer 344 rat strains differ not only in novelty- and amphetamine-induced behaviors, but also in dopamine transporter activity in vivo.
Gulley JM; Everett CV; Zahniser NR
Brain Res; 2007 Jun; 1151():32-45. PubMed ID: 17395161
[TBL] [Abstract][Full Text] [Related]
32. Effects of amphetamine exposure during adolescence on behavior and prelimbic cortex neuron activity in adulthood.
Sherrill LK; Gulley JM
Brain Res; 2018 Sep; 1694():111-120. PubMed ID: 29792867
[TBL] [Abstract][Full Text] [Related]
33. Neurochemical and behavioral differences between d-methamphetamine and d-amphetamine in rats.
Shoblock JR; Sullivan EB; Maisonneuve IM; Glick SD
Psychopharmacology (Berl); 2003 Feb; 165(4):359-69. PubMed ID: 12491026
[TBL] [Abstract][Full Text] [Related]
34. Amphetamine-induced in vivo release of dopamine in the striatum is influenced by local pH.
Guan XM; McBride WJ
Life Sci; 1988; 42(25):2625-31. PubMed ID: 2455210
[TBL] [Abstract][Full Text] [Related]
35. Behavioral sensitization to beta-phenylethylamine (PEA): enduring modifications of specific dopaminergic neuron systems in the rat.
Kuroki T; Tsutsumi T; Hirano M; Matsumoto T; Tatebayashi Y; Nishiyama K; Uchimura H; Shiraishi A; Nakahara T; Nakamura K
Psychopharmacology (Berl); 1990; 102(1):5-10. PubMed ID: 2392508
[TBL] [Abstract][Full Text] [Related]
36. The long-term effects of repeated amphetamine treatment in vivo on amphetamine, KCl and electrical stimulation evoked striatal dopamine release in vitro.
Castañeda E; Becker JB; Robinson TE
Life Sci; 1988; 42(24):2447-56. PubMed ID: 3374264
[TBL] [Abstract][Full Text] [Related]
37. Differentially altered mGluR1 and mGluR5 mRNA expression in rat caudate nucleus and nucleus accumbens in the development and expression of behavioral sensitization to repeated amphetamine administration.
Mao L; Wang JQ
Synapse; 2001 Sep; 41(3):230-40. PubMed ID: 11418936
[TBL] [Abstract][Full Text] [Related]
38. Estrous cycle-dependent variation in amphetamine-induced behaviors and striatal dopamine release assessed with microdialysis.
Becker JB; Cha JH
Behav Brain Res; 1989 Nov; 35(2):117-25. PubMed ID: 2818831
[TBL] [Abstract][Full Text] [Related]
39. An escalating dose/multiple high-dose binge pattern of amphetamine administration results in differential changes in the extracellular dopamine response profiles in caudate-putamen and nucleus accumbens.
Kuczenski R; Segal DS
J Neurosci; 1997 Jun; 17(11):4441-7. PubMed ID: 9151761
[TBL] [Abstract][Full Text] [Related]
40. A direct comparison of amphetamine-induced behaviours and regional brain dopamine release in the rat using intracerebral dialysis.
Sharp T; Zetterström T; Ljungberg T; Ungerstedt U
Brain Res; 1987 Jan; 401(2):322-30. PubMed ID: 3815099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
